Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SCYNEXIS INC (SCYX)
|
Add to portfolio |
|
|
|
| Price: |
$7.70
| | Metrics |
| OS: |
37.2
|
M
| |
52
|
% ROE
|
| Market cap: |
$286
|
M
| |
25
|
% ROIC
|
|
Net cash:
|
$57.9
|
M
| |
$1.56
|
per share
|
|
EV:
|
$228
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
$21.3
|
M
| |
10.7
|
x EV/EBIT
|
| EPS |
$0.86
| |
8.9
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 5.1 | 13.2 | 0.0 | 0.1 | 0.3 | 0.3 | 0.3 | 0.3 |
| Revenue growth | -61.3% | | -100.0% | -52.9% | 0.0% | 0.0% | 0.0% | -79.5% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -29.6 |
| Gross profit | 5.1 | 13.2 | 0.0 | 0.1 | 0.3 | 0.3 | 0.3 | 29.9 |
| Gross margin | 100.0% | 100.0% | | 100.0% | 100.0% | 100.0% | 100.0% | 11624.5% |
| Selling, general and administrative | 90.8 | 74.0 | 14.6 | 10.6 | 8.7 | 8.3 | 8.0 | 12.2 |
| Research and development | | | 36.5 | 38.4 | 21.6 | 18.3 | 20.1 | 16.4 |
| EBITA | -89.1 | -66.1 | -51.1 | -48.9 | -30.0 | -26.3 | -27.8 | -27.3 |
| EBITA margin | -1750.4% | -502.4% | | -40430.6% | -11666.5% | -10241.2% | -10823.7% | -10637.0% |
| Amortization of intangibles | 0.7 | 0.2 | | | | | | |
| EBIT | -89.8 | -66.3 | -51.1 | -48.9 | -30.0 | -26.3 | -27.8 | -27.3 |
| EBIT margin | -1764.2% | -503.9% | | -40430.6% | -11666.5% | -10241.2% | -10823.7% | -10637.0% |
| Pre-tax income | -67.5 | -36.0 | -58.3 | -53.7 | -19.2 | -25.1 | -30.0 | -28.3 |
| Income taxes | -4.7 | -3.1 | -3.1 | 0.0 | -6.7 | 0.0 | 0.0 | 0.0 |
| Tax rate | 7.0% | 8.6% | 5.4% | 0.0% | 35.1% | 0.0% | 0.0% | 0.0% |
| Net income | -62.8 | -32.9 | -55.2 | -53.7 | -12.5 | -25.1 | -30.0 | -32.6 |
| Net margin | -1233.7% | -249.7% | | -44388.4% | -4851.4% | -9751.0% | -11668.9% | -12693.8% |
| |
| Diluted EPS | ($1.47) | ($1.25) | ($5.15) | ($9.58) | ($0.28) | ($0.94) | ($1.58) | ($2.68) |
| Shares outstanding (diluted) | 42.6 | 26.4 | 10.7 | 5.6 | 43.9 | 26.7 | 19.0 | 12.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|